Search

Search Constraints

You searched for: Author/Creator Murgioni, Sabina

Search Results

1. Angiogenesis inhibitors and symptomatic anal ulcers in metastatic colorectal cancer patients**. (4th March 2018)

2. Bone metastases from neuroendocrine tumors: clinical and biological considerations. Issue 7 (27th June 2022)

3. Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases. (2021)

4. Dual inhibition of mTOR pathway and VEGF signalling in neuroendocrine neoplasms: From bench to bedside. Issue 9 (November 2015)

5. MTOR pathway and somatostatin receptors expression intratumor-heterogeneity in ileal NETs. Issue 7 (10th June 2021)

6. Phase II randomised study of maintenance treatment with bevacizumab or bevacizumab plus metronomic chemotherapy after first-line induction with FOLFOXIRI plus Bevacizumab for metastatic colorectal cancer patients: the MOMA trial. (March 2019)

7. Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations. (April 2019)

8. Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors. (25th May 2017)

9. Ramucirumab: the long and winding road toward being an option for mCRC treatment. (4th May 2019)

10. Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials. (March 2016)